Showing 1 - 3 results of 3 for search 'Zhizhen Hu', query time: 0.01s Refine Results
  1. 1
    WCN25-679 PEGMOLESATIDE FOR THE TREATMENT OF ANEMIA IN NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS: POST-HOC ANALYSIS OF A PHASE 3 TRIAL

    WCN25-679 PEGMOLESATIDE FOR THE TREATMENT OF ANEMIA IN NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS: POST-HOC ANALYSIS OF A PHASE 3 TRIAL by Xueqing Yu, Jianteng Xie, Aicheng Yang, Hongyu Qiu, Xiaomei Peng, Wanhong Lu, Qinkai Chen, Aimin Zhong, Shuifu Tang, Zhizhen Hu, Ping Li

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Overview of preclinical and phase II clinical studies on Pegmolesatide’s long-term erythropoiesis stimulating effect via EPOR-mediated signal transduction

    Overview of preclinical and phase II clinical studies on Pegmolesatide’s long-term erythropoiesis stimulating effect via EPOR-mediated signal transduction by Xiaoying Ma, Zhen Li, Lu Zhang, Hui Qian, Qinkai Chen, Ye Tao, Yunfan Li, Dandan Wang, Zhizhen Hu, Weili Luo, Ping Li, Hai Yu, Changlin Mei, Xueqing Yu, Yuanfeng Zhou

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Correction: Overview of preclinical and phase II clinical studies on Pegmolesatide’s long-term erythropoiesis stimulating effect via EPOR-mediated signal transduction

    Correction: Overview of preclinical and phase II clinical studies on Pegmolesatide’s long-term erythropoiesis stimulating effect via EPOR-mediated signal transduction by Xiaoying Ma, Zhen Li, Lu Zhang, Hui Qian, Qinkai Chen, Ye Tao, Yunfan Li, Dandan Wang, Zhizhen Hu, Weili Luo, Ping Li, Hai Yu, Changlin Mei, Xueqing Yu, Yuanfeng Zhou

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: